- Home
- HHS vs MDAI Comparison
HHS vs MDAI Comparison
Compare HHS & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HHS
- MDAI
- Stock Information
- Founded
- HHS 1923
- MDAI 2013
- Country
- HHS United States
- MDAI United States
- Employees
- HHS N/A
- MDAI N/A
- Industry
- HHS Advertising
- MDAI Medical/Dental Instruments
- Sector
- HHS Consumer Discretionary
- MDAI Health Care
- Exchange
- HHS Nasdaq
- MDAI Nasdaq
- Market Cap
- HHS 37.0M
- MDAI 33.1M
- IPO Year
- HHS N/A
- MDAI N/A
- Fundamental
- Price
- HHS $4.52
- MDAI $1.24
- Analyst Decision
- HHS
- MDAI Strong Buy
- Analyst Count
- HHS 0
- MDAI 2
- Target Price
- HHS N/A
- MDAI $4.75
- AVG Volume (30 Days)
- HHS 20.2K
- MDAI 142.8K
- Earning Date
- HHS 05-16-2025
- MDAI 05-13-2025
- Dividend Yield
- HHS N/A
- MDAI N/A
- EPS Growth
- HHS N/A
- MDAI N/A
- EPS
- HHS N/A
- MDAI N/A
- Revenue
- HHS $185,242,000.00
- MDAI $29,581,000.00
- Revenue This Year
- HHS $6.54
- MDAI N/A
- Revenue Next Year
- HHS N/A
- MDAI $102.58
- P/E Ratio
- HHS N/A
- MDAI N/A
- Revenue Growth
- HHS N/A
- MDAI 63.83
- 52 Week Low
- HHS $4.27
- MDAI $0.82
- 52 Week High
- HHS $8.87
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- HHS 45.88
- MDAI 46.29
- Support Level
- HHS $4.77
- MDAI $1.25
- Resistance Level
- HHS $4.81
- MDAI $1.32
- Average True Range (ATR)
- HHS 0.33
- MDAI 0.06
- MACD
- HHS -0.02
- MDAI 0.01
- Stochastic Oscillator
- HHS 23.17
- MDAI 52.38
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.